Who owns ACTUATE THERAPEUTICS INC?
- Ticker: ACTU
- CUSIP Number: 005083100
Tip: Access positions for across all investors
Analyze quarterly positions in Actuate Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Actuate Therapeutics stock
Who bought or sold ACTUATE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BIOS Capital Management | 10M | $28M | 0% | Mar 2026 |
|
| Voss Capital | 1.3M | $8.0M | 45% | Dec 2025 |
|
| Vanguard Group | 529k | $3.2M | 67% | Dec 2025 |
|
| BlackRock | 427k | $1.2M | -1% | Mar 2026 |
|
| Vanguard Capital Management | 401k | $1.1M | 100% | Mar 2026 |
|
| Geode Capital Management | 228k | $626k | 10% | Mar 2026 |
|
| Connective Capital Management | 113k | $310k | 100% | Mar 2026 |
|
| Northern Trust | 101k | $621k | 19% | Dec 2025 |
|
| Texas Capital Bank Wealth Management Services | 95k | $259k | 0% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 63k | $172k | 100% | Mar 2026 |
|
| State Street Corporation | 56k | $345k | 13% | Dec 2025 |
|
| Vanguard Portfolio Management | 56k | $152k | 100% | Mar 2026 |
|
| ABS Direct Equity Fund | 50k | $137k | 658% | Mar 2026 |
|
| Rock Creek Group | 39k | $108k | 80% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 36k | $100k | 291% | Mar 2026 |
|
| SFMG Wealth Advisors | 33k | $90k | 65% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 31k | $86k | 70% | Mar 2026 |
|
| Bridgeway Capital Management | 31k | $190k | 100% | Dec 2025 |
|
| AQR Capital Management | 27k | $74k | 100% | Mar 2026 |
|
| Charles Schwab Investment Management | 24k | $146k | 61% | Dec 2025 |
|
| Royal Bank of Canada | 22k | $61k | 72% | Mar 2026 |
|
| Gleason Group | 19k | $52k | 0% | Mar 2026 |
|
| Bank of New York Mellon | 15k | $42k | 23% | Mar 2026 |
|
| Barclays | 15k | $92k | 69% | Dec 2025 |
|
| LPL Financial | 13k | $36k | 0% | Mar 2026 |
|
| Goldman Sachs Group | 12k | $34k | 100% | Mar 2026 |
|
| Bank of America Corporation | 11k | $30k | 100% | Mar 2026 |
|
| Susquehanna International | 10k | $63k | 100% | Dec 2025 |
|
| Rhumbline Advisers | 9.4k | $26k | -2% | Mar 2026 |
|
| Morgan Stanley | 6.9k | $19k | -48% | Mar 2026 |
|
| Global Retirement Partners | 6.3k | $38k | 0% | Dec 2025 |
|
| New York State Common Retirement Fund | 6.2k | $17k | 0% | Mar 2026 |
|
| Wells Fargo & Company | 5.9k | $16k | -71% | Mar 2026 |
|
| Vanguard Global Advisers | 5.1k | $14k | 100% | Mar 2026 |
|
| Mirae Asset Global Etfs Holdings | 4.5k | $12k | 2% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 2.5k | $6.8k | 4% | Mar 2026 |
|
| UBS Group | 2.0k | $5.3k | -62% | Mar 2026 |
|
| Tower Research Capital | 1.6k | $10k | 0% | Dec 2025 |
|
| Legal & General Group | 1.1k | $3.0k | -13% | Mar 2026 |
|
| Advisor Group Holdings | 1.0k | $6.1k | 0% | Dec 2025 |
|
| Summit Investment Advisors | 601.00 | $1.6k | 0% | Mar 2026 |
|
| Russell Investments | 584.00 | $1.6k | 20% | Mar 2026 |
|
| Citigroup | 498.00 | $1.4k | 100% | Mar 2026 |
|
| GAMMA Investing | 286.00 | $784.011800 | 100% | Mar 2026 |
|
| FMR | 280.00 | $1.7k | -51% | Dec 2025 |
|
| NISA Investment Advisors | 87.00 | $237.997200 | 100% | Mar 2026 |
|
| Essential Partners | 48.00 | $132.000000 | 100% | Mar 2026 |
|
| CWM | 44.00 | $0 | -14% | Dec 2025 |
|
| Sterling Capital Management | 40.00 | $110.000000 | 0% | Mar 2026 |
|
| EverSource Wealth Advisors | 35.00 | $105.000000 | 1650% | Mar 2026 |
|
| Pnc Financial Services | 17.00 | $46.999900 | 100% | Mar 2026 |
|
| True Wealth Design | 14.00 | $38.999800 | 1300% | Mar 2026 |
|
| Rothschild Investment | 13.00 | $35.999600 | 100% | Mar 2026 |
|
| SRS Capital Advisors | 9.00 | $25.000200 | 100% | Mar 2026 |
|
| Farther Finance Advisors | 7.00 | $17.000200 | 100% | Mar 2026 |
|
| Wealth Preservation Advisors | 7.00 | $19.000100 | 100% | Mar 2026 |
|
| MAI Wealth Advisors | 6.00 | $16.999800 | 100% | Mar 2026 |
|
| Root Financial Partners | 5.00 | $14.000000 | 100% | Mar 2026 |
|
| IFP Advisors | 1.00 | $3.000000 | 100% | Mar 2026 |
|
| SJS Investment Consulting | 1.00 | $3.000000 | 100% | Mar 2026 |
|
Who sold out of Actuate Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Dec 2025 | 17k | $102k |
| Jpmorgan Chase & Co | Sep 2025 | 2.5k | $17k |
| Prosight Management | Sep 2025 | 885.00 | $5.9k |
| California State Teachers Retirement System | Dec 2025 | 585.00 | $3.6k |
| Amalgamated Bank | Dec 2025 | 298.00 | $2.0k |